Table of Content

1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Market by Application
1.3.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Influenza Drugs and Vaccines Revenue by Region
2.2.1 Global Influenza Drugs and Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Influenza Drugs and Vaccines Revenue by Region (2018-2024)
2.2.3 Global Influenza Drugs and Vaccines Revenue by Region (2024-2029)
2.2.4 Global Influenza Drugs and Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Influenza Drugs and Vaccines Sales by Region
2.4.1 Global Influenza Drugs and Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Influenza Drugs and Vaccines Sales by Region (2018-2024)
2.4.3 Global Influenza Drugs and Vaccines Sales by Region (2024-2029)
2.4.4 Global Influenza Drugs and Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Influenza Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Influenza Drugs and Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Influenza Drugs and Vaccines in 2022
3.2 Global Influenza Drugs and Vaccines Revenue by Manufacturers
3.2.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2022
3.3 Global Key Players of Influenza Drugs and Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Influenza Drugs and Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Influenza Drugs and Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Influenza Drugs and Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Drugs and Vaccines Sales by Type
4.1.1 Global Influenza Drugs and Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Influenza Drugs and Vaccines Revenue by Type
4.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Influenza Drugs and Vaccines Price by Type
4.3.1 Global Influenza Drugs and Vaccines Price by Type (2018-2024)
4.3.2 Global Influenza Drugs and Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Influenza Drugs and Vaccines Sales by Application
5.1.1 Global Influenza Drugs and Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Influenza Drugs and Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Influenza Drugs and Vaccines Revenue by Application
5.2.1 Global Influenza Drugs and Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Influenza Drugs and Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Influenza Drugs and Vaccines Price by Application
5.3.1 Global Influenza Drugs and Vaccines Price by Application (2018-2024)
5.3.2 Global Influenza Drugs and Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Influenza Drugs and Vaccines Market Size by Type
6.1.1 US & Canada Influenza Drugs and Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Influenza Drugs and Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Influenza Drugs and Vaccines Market Size by Application
6.2.1 US & Canada Influenza Drugs and Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Influenza Drugs and Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Influenza Drugs and Vaccines Market Size by Country
6.3.1 US & Canada Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Influenza Drugs and Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Influenza Drugs and Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Influenza Drugs and Vaccines Market Size by Type
7.1.1 Europe Influenza Drugs and Vaccines Sales by Type (2018-2029)
7.1.2 Europe Influenza Drugs and Vaccines Revenue by Type (2018-2029)
7.2 Europe Influenza Drugs and Vaccines Market Size by Application
7.2.1 Europe Influenza Drugs and Vaccines Sales by Application (2018-2029)
7.2.2 Europe Influenza Drugs and Vaccines Revenue by Application (2018-2029)
7.3 Europe Influenza Drugs and Vaccines Market Size by Country
7.3.1 Europe Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Influenza Drugs and Vaccines Sales by Country (2018-2029)
7.3.3 Europe Influenza Drugs and Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Influenza Drugs and Vaccines Market Size
8.1.1 China Influenza Drugs and Vaccines Sales (2018-2029)
8.1.2 China Influenza Drugs and Vaccines Revenue (2018-2029)
8.2 China Influenza Drugs and Vaccines Market Size by Application
8.2.1 China Influenza Drugs and Vaccines Sales by Application (2018-2029)
8.2.2 China Influenza Drugs and Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Influenza Drugs and Vaccines Market Size by Type
9.1.1 Asia Influenza Drugs and Vaccines Sales by Type (2018-2029)
9.1.2 Asia Influenza Drugs and Vaccines Revenue by Type (2018-2029)
9.2 Asia Influenza Drugs and Vaccines Market Size by Application
9.2.1 Asia Influenza Drugs and Vaccines Sales by Application (2018-2029)
9.2.2 Asia Influenza Drugs and Vaccines Revenue by Application (2018-2029)
9.3 Asia Influenza Drugs and Vaccines Sales by Region
9.3.1 Asia Influenza Drugs and Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Influenza Drugs and Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Influenza Drugs and Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Influenza Drugs and Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Influenza Drugs and Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL
11.1.1 CSL Company Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CSL Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Information
11.2.2 Bristol Myers Squibb Overview
11.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol Myers Squibb Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 AstraZeneca Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Eli Lilly Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Overview
11.5.3 Roche Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Roche Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Overview
11.7.3 Novartis Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novartis Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Pfizer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sanofi Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Bayer
11.10.1 Bayer Company Information
11.10.2 Bayer Overview
11.10.3 Bayer Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Bayer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Recent Developments
11.11 Celgene
11.11.1 Celgene Company Information
11.11.2 Celgene Overview
11.11.3 Celgene Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Celgene Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Celgene Recent Developments
11.12 Seqirus
11.12.1 Seqirus Company Information
11.12.2 Seqirus Overview
11.12.3 Seqirus Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Seqirus Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Seqirus Recent Developments
11.13 Protein Sciences Corporation
11.13.1 Protein Sciences Corporation Company Information
11.13.2 Protein Sciences Corporation Overview
11.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Protein Sciences Corporation Recent Developments
11.14 Serum Institute of India
11.14.1 Serum Institute of India Company Information
11.14.2 Serum Institute of India Overview
11.14.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Serum Institute of India Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Serum Institute of India Recent Developments
11.15 Emergent Biosolutions
11.15.1 Emergent Biosolutions Company Information
11.15.2 Emergent Biosolutions Overview
11.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Emergent Biosolutions Recent Developments
11.16 BioCryst Pharmaceuticals
11.16.1 BioCryst Pharmaceuticals Company Information
11.16.2 BioCryst Pharmaceuticals Overview
11.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 BioCryst Pharmaceuticals Recent Developments
11.17 Alvogen
11.17.1 Alvogen Company Information
11.17.2 Alvogen Overview
11.17.3 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Alvogen Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Alvogen Recent Developments
11.18 Viatris
11.18.1 Viatris Company Information
11.18.2 Viatris Overview
11.18.3 Viatris Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Viatris Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Viatris Recent Developments
11.19 Hulan Bio
11.19.1 Hulan Bio Company Information
11.19.2 Hulan Bio Overview
11.19.3 Hulan Bio Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Hulan Bio Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Hulan Bio Recent Developments
11.20 Changchun Institute of Biological
11.20.1 Changchun Institute of Biological Company Information
11.20.2 Changchun Institute of Biological Overview
11.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Changchun Institute of Biological Recent Developments
11.21 Jiangsu GDK
11.21.1 Jiangsu GDK Company Information
11.21.2 Jiangsu GDK Overview
11.21.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Jiangsu GDK Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Jiangsu GDK Recent Developments
11.22 Sinovac
11.22.1 Sinovac Company Information
11.22.2 Sinovac Overview
11.22.3 Sinovac Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Sinovac Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Sinovac Recent Developments
11.23 Beike Bio
11.23.1 Beike Bio Company Information
11.23.2 Beike Bio Overview
11.23.3 Beike Bio Influenza Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.23.4 Beike Bio Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Beike Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Influenza Drugs and Vaccines Industry Chain Analysis
12.2 Influenza Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Drugs and Vaccines Production Mode & Process
12.4 Influenza Drugs and Vaccines Sales and Marketing
12.4.1 Influenza Drugs and Vaccines Sales Channels
12.4.2 Influenza Drugs and Vaccines Distributors
12.5 Influenza Drugs and Vaccines Customers
13 Market Dynamics
13.1 Influenza Drugs and Vaccines Industry Trends
13.2 Influenza Drugs and Vaccines Market Drivers
13.3 Influenza Drugs and Vaccines Market Challenges
13.4 Influenza Drugs and Vaccines Market Restraints
14 Key Findings in The Global Influenza Drugs and Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Influenza Drugs
Table 3. Major Manufacturers of Influenza Vaccines
Table 4. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Influenza Drugs and Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Influenza Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Influenza Drugs and Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 12. Global Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 13. Global Influenza Drugs and Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Influenza Drugs and Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Influenza Drugs and Vaccines Sales by Manufacturers (2018-2024) & (Tons)
Table 16. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Influenza Drugs and Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Influenza Drugs and Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Influenza Drugs and Vaccines Price by Manufacturers 2018-2024 (US$/Kg)
Table 21. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs and Vaccines as of 2022)
Table 23. Global Key Manufacturers of Influenza Drugs and Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Influenza Drugs and Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Influenza Drugs and Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 28. Global Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 29. Global Influenza Drugs and Vaccines Sales Share by Type (2018-2024)
Table 30. Global Influenza Drugs and Vaccines Sales Share by Type (2024-2029)
Table 31. Global Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Influenza Drugs and Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Influenza Drugs and Vaccines Revenue Share by Type (2024-2029)
Table 35. Influenza Drugs and Vaccines Price by Type (2018-2024) & (US$/Kg)
Table 36. Global Influenza Drugs and Vaccines Price Forecast by Type (2024-2029) & (US$/Kg)
Table 37. Global Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 38. Global Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 39. Global Influenza Drugs and Vaccines Sales Share by Application (2018-2024)
Table 40. Global Influenza Drugs and Vaccines Sales Share by Application (2024-2029)
Table 41. Global Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Influenza Drugs and Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Influenza Drugs and Vaccines Revenue Share by Application (2024-2029)
Table 45. Influenza Drugs and Vaccines Price by Application (2018-2024) & (US$/Kg)
Table 46. Global Influenza Drugs and Vaccines Price Forecast by Application (2024-2029) & (US$/Kg)
Table 47. US & Canada Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 48. US & Canada Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 49. US & Canada Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 52. US & Canada Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 53. US & Canada Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 59. US & Canada Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 60. Europe Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 61. Europe Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 62. Europe Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 65. Europe Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 66. Europe Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 72. Europe Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 73. China Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 74. China Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 75. China Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 78. China Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 79. China Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 82. Asia Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 83. Asia Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 86. Asia Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 87. Asia Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Influenza Drugs and Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Influenza Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Influenza Drugs and Vaccines Sales by Region (2018-2024) & (Tons)
Table 93. Asia Influenza Drugs and Vaccines Sales by Region (2024-2029) & (Tons)
Table 94. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Type (2018-2024) & (Tons)
Table 95. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Type (2024-2029) & (Tons)
Table 96. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Application (2018-2024) & (Tons)
Table 99. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Application (2024-2029) & (Tons)
Table 100. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Country (2018-2024) & (Tons)
Table 106. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales by Country (2024-2029) & (Tons)
Table 107. CSL Company Information
Table 108. CSL Description and Major Businesses
Table 109. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 110. CSL Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Recent Developments
Table 112. Bristol Myers Squibb Company Information
Table 113. Bristol Myers Squibb Description and Major Businesses
Table 114. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 115. Bristol Myers Squibb Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bristol Myers Squibb Recent Developments
Table 117. AstraZeneca Company Information
Table 118. AstraZeneca Description and Major Businesses
Table 119. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 120. AstraZeneca Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AstraZeneca Recent Developments
Table 122. Eli Lilly Company Information
Table 123. Eli Lilly Description and Major Businesses
Table 124. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 125. Eli Lilly Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Eli Lilly Recent Developments
Table 127. Roche Company Information
Table 128. Roche Description and Major Businesses
Table 129. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 130. Roche Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Roche Recent Developments
Table 132. GlaxoSmithKline Company Information
Table 133. GlaxoSmithKline Description and Major Businesses
Table 134. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 135. GlaxoSmithKline Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. GlaxoSmithKline Recent Developments
Table 137. Novartis Company Information
Table 138. Novartis Description and Major Businesses
Table 139. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 140. Novartis Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Novartis Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 145. Pfizer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Sanofi Company Information
Table 148. Sanofi Description and Major Businesses
Table 149. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 150. Sanofi Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Sanofi Recent Developments
Table 152. Bayer Company Information
Table 153. Bayer Description and Major Businesses
Table 154. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 155. Bayer Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bayer Recent Developments
Table 157. Celgene Company Information
Table 158. Celgene Description and Major Businesses
Table 159. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 160. Celgene Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Celgene Recent Developments
Table 162. Seqirus Company Information
Table 163. Seqirus Description and Major Businesses
Table 164. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 165. Seqirus Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Seqirus Recent Developments
Table 167. Protein Sciences Corporation Company Information
Table 168. Protein Sciences Corporation Description and Major Businesses
Table 169. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 170. Protein Sciences Corporation Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Protein Sciences Corporation Recent Developments
Table 172. Serum Institute of India Company Information
Table 173. Serum Institute of India Description and Major Businesses
Table 174. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 175. Serum Institute of India Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Serum Institute of India Recent Developments
Table 177. Emergent Biosolutions Company Information
Table 178. Emergent Biosolutions Description and Major Businesses
Table 179. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 180. Emergent Biosolutions Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Emergent Biosolutions Recent Developments
Table 182. BioCryst Pharmaceuticals Company Information
Table 183. BioCryst Pharmaceuticals Description and Major Businesses
Table 184. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 185. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. BioCryst Pharmaceuticals Recent Developments
Table 187. Alvogen Company Information
Table 188. Alvogen Description and Major Businesses
Table 189. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 190. Alvogen Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Alvogen Recent Developments
Table 192. Viatris Company Information
Table 193. Viatris Description and Major Businesses
Table 194. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 195. Viatris Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Viatris Recent Developments
Table 197. Hulan Bio Company Information
Table 198. Hulan Bio Description and Major Businesses
Table 199. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 200. Hulan Bio Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Hulan Bio Recent Developments
Table 202. Changchun Institute of Biological Company Information
Table 203. Changchun Institute of Biological Description and Major Businesses
Table 204. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 205. Changchun Institute of Biological Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Changchun Institute of Biological Recent Developments
Table 207. Jiangsu GDK Company Information
Table 208. Jiangsu GDK Description and Major Businesses
Table 209. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 210. Jiangsu GDK Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Jiangsu GDK Recent Developments
Table 212. Sinovac Company Information
Table 213. Sinovac Description and Major Businesses
Table 214. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 215. Sinovac Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Sinovac Recent Developments
Table 217. Beike Bio Company Information
Table 218. Beike Bio Description and Major Businesses
Table 219. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2024)
Table 220. Beike Bio Influenza Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 221. Beike Bio Recent Developments
Table 222. Key Raw Materials Lists
Table 223. Raw Materials Key Suppliers Lists
Table 224. Influenza Drugs and Vaccines Distributors List
Table 225. Influenza Drugs and Vaccines Customers List
Table 226. Influenza Drugs and Vaccines Market Trends
Table 227. Influenza Drugs and Vaccines Market Drivers
Table 228. Influenza Drugs and Vaccines Market Challenges
Table 229. Influenza Drugs and Vaccines Market Restraints
Table 230. Research Programs/Design for This Report
Table 231. Key Data Information from Secondary Sources
Table 232. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Influenza Drugs and Vaccines Market Share by Type in 2022 & 2029
Figure 4. Influenza Drugs Product Picture
Figure 5. Influenza Vaccines Product Picture
Figure 6. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Influenza Drugs and Vaccines Market Share by Application in 2022 & 2029
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Online Pharmacy
Figure 11. Influenza Drugs and Vaccines Report Years Considered
Figure 12. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Influenza Drugs and Vaccines Revenue 2018-2029 (US$ Million)
Figure 14. Global Influenza Drugs and Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2018-2029)
Figure 16. Global Influenza Drugs and Vaccines Sales 2018-2029 ((Tons)
Figure 17. Global Influenza Drugs and Vaccines Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Influenza Drugs and Vaccines Sales YoY (2018-2029) & (Tons)
Figure 19. US & Canada Influenza Drugs and Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Influenza Drugs and Vaccines Sales YoY (2018-2029) & (Tons)
Figure 21. Europe Influenza Drugs and Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Influenza Drugs and Vaccines Sales YoY (2018-2029) & (Tons)
Figure 23. China Influenza Drugs and Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Influenza Drugs and Vaccines Sales YoY (2018-2029) & (Tons)
Figure 25. Asia (excluding China) Influenza Drugs and Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales YoY (2018-2029) & (Tons)
Figure 27. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Influenza Drugs and Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Influenza Drugs and Vaccines in the World: Market Share by Influenza Drugs and Vaccines Revenue in 2022
Figure 30. Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 32. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 33. Global Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 34. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Influenza Drugs and Vaccines Revenue Share by Country (2018-2029)
Figure 40. US & Canada Influenza Drugs and Vaccines Sales Share by Country (2018-2029)
Figure 41. U.S. Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 44. Europe Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 45. Europe Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 46. Europe Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 47. Europe Influenza Drugs and Vaccines Revenue Share by Country (2018-2029)
Figure 48. Europe Influenza Drugs and Vaccines Sales Share by Country (2018-2029)
Figure 49. Germany Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. France Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 54. China Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 55. China Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 56. China Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 57. China Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 58. Asia Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 59. Asia Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 60. Asia Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 61. Asia Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 62. Asia Influenza Drugs and Vaccines Revenue Share by Region (2018-2029)
Figure 63. Asia Influenza Drugs and Vaccines Sales Share by Region (2018-2029)
Figure 64. Japan Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. India Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Influenza Drugs and Vaccines Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Influenza Drugs and Vaccines Sales Share by Country (2018-2029)
Figure 75. Brazil Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Influenza Drugs and Vaccines Revenue (2018-2029) & (US$ Million)
Figure 80. Influenza Drugs and Vaccines Value Chain
Figure 81. Influenza Drugs and Vaccines Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed